Bal Pharma reports standalone net profit of Rs 4.38 crore in the March 2021 quarter

Sales rise 108.14% to Rs 70.29 crore

Net profit of Bal Pharma reported to Rs 4.38 crore in the quarter ended March 2021 as against net loss of Rs 3.52 crore during the previous quarter ended March 2020. Sales rose 108.14% to Rs 70.29 crore in the quarter ended March 2021 as against Rs 33.77 crore during the previous quarter ended March 2020.

For the full year,net profit reported to Rs 9.10 crore in the year ended March 2021 as against net loss of Rs 8.90 crore during the previous year ended March 2020. Sales rose 46.08% to Rs 249.31 crore in the year ended March 2021 as against Rs 170.67 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales70.2933.77 108 249.31170.67 46 OPM %9.903.79 -10.564.03 - PBDT5.01-0.09 LP 17.06-2.04 LP PBT2.68-3.12 LP 9.80-9.07 LP NP4.38-3.52 LP 9.10-8.90 LP

Powered by Capital Market - Live News